The Peptide Atlas / Personalized From Bloodwork

Your blood
& the peptides
it asks for.

42Biomarkers indexed

11Peptides referenced

137Citations on file

5–7Days to report

Editorial notice. This service does not prescribe, sell, or compound peptides. Information is provided as research literature review tied to your biomarker profile.

Editor's Note · Issue 14

The bloodwork your doctor ordered didn't ask the questions you came in to answer.

A standard annual panel checks four to six markers. None of them index the growth-hormone axis, the melanocortin pathway, or the systemic inflammatory tone that determines whether a peptide protocol has a rational basis. We index those things.

The peptide market has run far ahead of the evidence. Compounding pharmacies, telehealth clinics, and grey-market vendors prescribe with a presumption of universal candidacy.¹¹ Total Virility was founded on the inverse premise: that a peptide recommendation should begin with a measurement, end with a citation, and contain no commercial conflict in between.

This volume covers eleven peptides — from BPC-157 and TB-500 to the GLP-1 incretins reshaping metabolic medicine.⁸¹¹ Each is mapped to a defined biomarker panel. Each rests on a published trial or mechanistic study. Each comes with the contraindications the marketing copy tends to omit.

— The editors

§ Method

A three-step process
borrowed from clinical research.

Full methodology →

Intake & assay selection

A six-minute structured intake records your symptoms, goals, medications, and contraindications. We select the assay panel that can answer the relevant questions — not a generic preset.

~6 min · digital · saved to your record

II.

Venous draw at any CLIA lab

A requisition routes to Quest or Labcorp. Walk in to any of 4,500+ patient service centers. Fasting is required for the metabolic subpanel; otherwise no preparation.

10 min · no appointment · ~4,500 locations

III.

Annotated peptide report

Each flagged biomarker is annotated to the peptide literature with author, journal, and PMID. Recommendations include a candidate stack, monitoring schedule, and explicit contraindications.

5–7 days · PDF + dashboard · share with your physician

§ Featured Monographs

Six of eleven
peptides in print.

Full library →

No. 01 · RecoveryBPC-157Body Protection Compound · pentadecapeptide

Synthetic peptide derived from human gastric juice protein. Studied for tendon-to-bone healing, soft-tissue repair, and intestinal-barrier function.1²

Read monograph →No. 02 · RecoveryTB-500Thymosin β-4 fragment · 43 aa

Actin-sequestering peptide investigated for wound healing, cardiac repair, and corneal epithelial recovery.5

Read monograph →No. 03 · MetabolicSemaglutideGLP-1 receptor agonist · 31 aa analog

FDA-approved weekly GLP-1 agonist. STEP-1 demonstrated −14.9% body weight at 68 weeks; SUSTAIN-6 showed cardiovascular benefit.8¹⁰

Read monograph →No. 05 · Growth axisCJC-1295GHRH(1–29) analog · DAC & non-DAC

Long-acting GHRH analog. Teichman et al. demonstrated sustained IGF-1 elevation in healthy adults; pulsatile pattern persists with co-secretagogue.13

Read monograph →No. 07 · Growth axisTesamorelinGHRH(1–44) analog · FDA-approved

Approved for HIV-associated lipodystrophy; Phase-2 data show reduction in hepatic fat fraction and visceral adipose tissue.17¹⁸

Read monograph →No. 08 · Sexual healthPT-141Bremelanotide · melanocortin agonist

Central MC3R/MC4R agonist. RECONNECT trials supported FDA approval for HSDD; investigational for PDE5i-refractory ED.19

Read monograph →

From the report

Every recommendation begins with a flagged biomarker.

The report is structured like a journal article: methods first (assays, reference ranges, sample handling), then a results section with flagged biomarkers, then a discussion mapping each flag to the peptide literature.

No flag without a citation. No recommendation without a contraindication section. No protocol without a monitoring schedule.

View full sample report →

Report № TV-2026-04827

Results · Growth Axis

p. 04 / 12

IGF-1 ng/mL142↓ Low

IGFBP-3 mg/L3.4Borderline

Cortisol AM µg/dL18.2Optimal

Prolactin ng/mL9.8Optimal

Fasting glucose mg/dL88Optimal

§ Discussion

Patient's IGF-1 sits at the 11th percentile for age-matched controls. A GHRH analog stack (CJC-1295 + ipamorelin) is supported by Teichman 2006¹³ with pulsatile preservation per Ionescu 2006¹⁴. See dosing windows, p. 7.

§ Readers write

Letters & cases.

I'd been on telehealth-prescribed semaglutide for nine months. The report flagged my lipase trending up and recommended a wash-out window. I'd have missed it.

M.T., 38·Metabolic panel · Issue 11

My IGF-1 came back at 96. I'd been considering an "anti-aging stack" from a clinic — turned out my pituitary had a reason worth investigating first.

J.R., 41·Growth axis · Issue 09

The contraindication section alone is worth the price. BPC-157 plus my baseline hsCRP, with the trial data inline — it changed the conversation with my sports-med doc.

D.S., 29·Recovery panel · Issue 13

I appreciate that the report tells me what isn't supported by evidence as clearly as what is. Melanotan II got a hard pass and a reason why.

R.K., 36·Complete atlas · Issue 12

Your blood& the peptidesit asks for.

The bloodwork your doctor ordered didn't ask the questions you came in to answer.

A three-step processborrowed from clinical research.